Do you know if you have an oval window or not? Take the check-up program and find out!
  • Русский
  • English

Useful literature

  1. Ognerubov D. V., Shchekochikhin D. Yu., Bogdanova A. A., Merkulov E. V. Ischemic stroke in a patient with an open oval window and thrombophilia. Cardiology and cardiovascular surgery. 2020;13(2):157-162.
  2. Ognerubov D. V., Merkulov E. V., Chechetkin A. O., Karshieva A. R., Tereshchenko A. S., Makeev M. I., Saidova M. A., Salikhov S. G., Samko A. N. Endovascular closure of the open oval window in divers with a history of decompression sickness. Literature review and own clinical observations. Nervous disease.- 2020 (2); pp. 23-27. DOI: 10.24411 / 2226-0757-2020-12176
  3. Kulesh A. A., Ognerubov D. V., Mekhryakov S. A., Merkulov E. V., syromyatnikova L. I., Tereshchenko A. S., Samko A. N., Shestakov V. V., Karakulova Yu.V. stroke associated with an open oval window: approaches to diagnosis and possibilities of endovascular prevention (clinical observations and literature review). Neurology, neuropsychiatry, and psychosomatics. 2020;12(2):72-78.
  4. Kulesh A. A., Shestakov V. V. open oval window and embolic cryptogenic stroke. Neurology, neuropsychiatry, and psychosomatics. 2019;11(2):4-11.
  5. Patent foramen ovale (PFO). American Heart Association. Accessed May 18, 2017.
  6. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Hagen PT, Scolz DG, Edwards WD. Mayo Clin Proc. 1984;59:17–20
  7. Mas J-L, Derumeaux G, Guillon B, et. al Moulisure or Anticoagulation vs. Antiplatelets after Stroke. N Engl J Med. 2017;377:1011–21.
  8. Lee JY, Song JK, Song JM, et al. Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol 2010;106: 129–34.
  9. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007;49:797–802.
  10. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005;112:1063–72.
  11. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11–2.
  12. Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092-1100. doi: 10.1056/NEJMoa1301440
  13. Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med.2017;377(11):1022-1032.doi: 10.1056/NEJMoa1610057 .
  14. Mas J-L, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs antiplatelets after stroke. N Engl J Med. 2017;377(11):1011-1021. doi: 10.1056/NEJMoa1705915
  15. Kent DM, Dahabreh IJ, Ruthazer R, et al. Anticoagulant vs anti¬platelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. Eur Heart J. 2015;36(35):2381-2389. doi: 10.1093/eurheartj/ehv252
  16. Wahl A, Juni P, Mono M-L, et al. Long-term propensity—score matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. 2012;125:803-812. doi:10.1161/CIRCULATIONAHA.111.030494
  17. Pristipino C, Sievert H, D’Ascenzo F, Mas JL, Meier B, Scacciatella P, Hildick-Smith D, Gaita F, Toni D, Kyrle P, Thomson J, Derumeaux G, Onorato E, Sibbing D, Germonpré P, Berti S, Chessa M, Bedogni F, Dudek D, Hornung M, Zamorano J. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. EuroIntervention. 2018 Aug 25. pii: EIJ-D-18-00622. doi: 10.4244/EIJ-D-18-00622